Immuno-Biological Laboratories Co., Ltd.【JP:4570】Balance sheet
Market cap
¥17B
P/E ratio
64x
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 1,284 | 974 | 2,574 | 2,510 | 1,544 | 1,034 | 604 | 508 | 614 | 734 | 826 |
| Accounts receivable, net | - | 249 | 220 | 193 | 203 | 209 | 171 | 199 | - | - | - | - |
| Inventories | - | 55 | 47 | 43 | 49 | 92 | 57 | 40 | 47 | 43 | 45 | 43 |
| Total current assets | - | 1,826 | 1,485 | 3,129 | 2,998 | 2,112 | 1,593 | 1,125 | 1,130 | 1,165 | 1,262 | 1,390 |
| Property, plant and equipment, net | - | 936 | 1,574 | 123 | 122 | 114 | 114 | 127 | 120 | 119 | 136 | 191 |
| Marketable securities, non-current | - | 121 | 55 | 108 | 105 | 687 | 596 | 514 | 400 | 95 | 95 | 95 |
| Total non-current assets | - | 1,312 | 1,871 | 297 | 297 | 877 | 780 | 713 | 576 | 269 | 356 | 455 |
| Total assets | - | 3,138 | 3,356 | 3,426 | 3,295 | 2,988 | 2,373 | 1,838 | 1,705 | 1,434 | 1,619 | 1,845 |
| Accounts payable | - | 5 | 7 | 1 | 8 | 5 | 5 | 7 | 4 | 6 | 4 | 4 |
| Short-term debt | - | - | - | - | - | - | 20 | 20 | 125 | 130 | 135 | 140 |
| Long-term debt, current | - | 102 | 80 | 146 | 146 | 109 | 66 | 11 | 4 | 6 | 16 | 29 |
| Total current liabilities | - | 233 | 165 | 234 | 302 | 550 | 398 | 145 | 228 | 252 | 258 | 281 |
| Long-term debt, non-current | - | 283 | 203 | 329 | 183 | 86 | 20 | 59 | 105 | 99 | 85 | 35 |
| Total non-current liabilities | - | 285 | 405 | 1,850 | 975 | 292 | 27 | 64 | 109 | 104 | 95 | 50 |
| Total liabilities | - | 518 | 570 | 2,084 | 1,277 | 843 | 425 | 209 | 337 | 356 | 353 | 331 |
| Common stock and paid-in capital | - | 2,725 | 2,925 | 3,576 | 4,305 | 4,617 | 5,090 | 5,090 | 5,090 | 5,090 | 1,090 | 1,090 |
| Retained earnings | - | -111 | -143 | -2,237 | -2,290 | -2,474 | -3,142 | -3,461 | -3,720 | -4,010 | 177 | 426 |
| Stockholders' equity | 2,795 | 2,620 | 2,786 | 1,341 | 2,018 | 2,146 | 1,948 | 1,629 | 1,368 | 1,079 | 1,265 | 1,514 |